Here is the latest on the Smiles study. We really hope that this is going to be such an exciting initiative and will provide a lasting legacy for us all to remember Grace by.
Update 27th January 2016
I am glad to say that Vicky Jones, our new clinical PhD student, has started work and is already collecting samples from children undergoing surgery, with the help of Dominic and his team. We are now planning the first set of analyses, to look for a possible biomarker that can predict the severity and clinical course of the children with spinal lipoma. In fact, only yesterday Vicky and I met with Dr Kevin Mills, who leads our mass spectrometry team, to plan exactly how the analysis will be done. We hope to start some analysis on his machine in the next couple of weeks. This will give us a ‘fingerprint’ of the fatty molecules in the brain fluid, blood and urine of the children, so we can see whether there are particular molecules that appear when the child has a lipoma, but not if a lipoma is absent. These will be our ‘candidate’ biomarkers for future study.
We are very excited to be about to get some data, after all the planning, and of course I will keep you informed once we have results.
Update July 2015
We are making progress, and the main work we have done is to get National Research Ethics Service (NRES) approval for the study. This has been an immense amount of work which I have done with valuable help from Vicky Jones (our new PhD student) and Dominic. I have attached the full application form that was submitted to the NRES committee so you can get further information. You will see how many diverse aspects the committee needs information on! The process was nevertheless helpful, as it led to a strengthening of the protocol we will follow (which I have also attached).
The good news is that the NRES committee has now given provisional approval, with a few outstanding questions we need to answer. Vicky and I have drafted our response and that will go to NRES in the next week. I hope that will lead to full approval which means we can then go ahead with collecting and analysing samples.
The next step will be for a small number of samples to be collected from Dominic’s clinic so we can develop the laboratory method for identifying the biomarker. Dr Kit-Yi Leung is a postdoctoral research fellow in my group, and she is very experienced in the mass spectrometry method we will use. In addition, Dr Kevin Mills runs the ICH mass spectrometry service and he will help Kit-Yi with the initial assays. Once we have worked out how best to prepare the samples, and run them through the machine, then we can start the analysis in earnest.
I am keen that Vicky does the main part of the work as her PhD. You will remember she is a trainee neurosurgeon, and we have agreed that she will do some limited neurosurgical work with Dominic, to further her clinical training. However, 95% of her time will be spent on research, and doing the biomarker analysis in the Smiles with Grace project will be her main task. I mentioned before that she is now on maternity leave – her baby was born in February, and she has asked to return to work on 1st Jan 2016. So the plan is that before the end of 2015 we will have some preliminary results on the samples, and then from January 2016 Vicky will be working full time to advance the project as quickly as possible, as part of her PhD.
Smiles Study – Prof Andrew Copp (Professor of Developmental Neurobiology at the Institute of Child Health at UCL) and Mr Dominic Thompson (Neuro-Surgeon, Great Ormond Street Hospital)
‘Spinal lipoma’ describes a group of childhood conditions in which fatty tissue (lipoma) is present from before birth, stuck to the lower end of the spinal cord. This condition is estimated to occur once in every 4,000 pregnancies and can lead to progressive disability as children grow older. Weakness or pain and disorders of urination are commonly encountered because of gradual stretching of the spinal cord during growth. Surgical ‘untethering’ operations are performed regularly by Mr Dominic Thompson at Great Ormond Street Hospital.
Only a proportion of children with spinal lipoma deteriorate and need surgery. Others remain healthy and need no operation. Therefore, surgeons are faced with a dilemma: whether to operate on all children when they are young – and subject many to an unnecessary operation – or to operate later, only if symptoms appear. Delaying the operation in children who deteriorate might mean a worse outcome than if they were operated upon earlier in life.
What is needed is a simple blood or urine test that could be performed on very young children, when they are first diagnosed with spinal lipoma. The test would guide the doctor as to whether the child is at high risk of deterioration, and so needs early surgery, or is at low risk in which case surgery could be delayed and perhaps avoided altogether. In the Smiles Project, we will carry out research with the aim of developing such a test.
Our idea is that fat molecules may leave the spinal fluid and enter the bloodstream and urine of children with particularly severe spinal lipomas. These molecules will be detected using a sophisticated procedure called ‘mass spectrometry’ in which all the different fat molecules are separated out, to provide a ‘fingerprint’ for that particular patient. By comparing children who deteriorate with those who stay healthy, we hope to identify a fingerprint that can predict whether a particular child is likely to deteriorate or not. If successful, the Smiles Project could significantly improve how children with spinal lipoma are managed clinically in the future.